Immune response to hepatitis B vaccination: a review of the clinical evidence
CADTH
Record ID 32012000667
English
Authors' recommendations:
Evidence from randomized controlled trials and non-randomized studies indicates that the combined hepatitis A/hepatitis B (HAV/HBV) vaccine may be more effective than the HBV vaccine for generating an immune response to hepatitis B virus, however the data are not conclusive. No evidence-based guidelines recommending the use of HAV/HBV vaccine in non-responders to HBV vaccination were identified.
Details
Project Status:
Completed
Year Published:
2012
URL for published report:
http://www.cadth.ca/media/pdf/htis/mar-2012/RC0338%20Hepatitis%20B%20Vaccination%20Final.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Vaccination
- Hepatitis B
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.